Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study.

Pecorelli N, Pagnanelli M, Cinelli L, Di Salvo F, Partelli S, Crippa S, Tamburrino D, Castoldi R, Belfiori G, Reni M, Falconi M, Balzano G.

Front Oncol. 2019 Nov 26;9:1299. doi: 10.3389/fonc.2019.01299. eCollection 2019.

2.

Impact of diet-induced obesity on the mouse brain phosphoproteome.

Siino V, Amato A, Di Salvo F, Caldara GF, Filogamo M, James P, Vasto S.

J Nutr Biochem. 2018 Aug;58:102-109. doi: 10.1016/j.jnutbio.2018.04.015. Epub 2018 May 1.

PMID:
29886190
3.

Hypofractionated Whole-Breast Irradiation With or Without Boost in Elderly Patients: Clinical Evaluation of an Italian Experience.

De Santis MC, Bonfantini F, Di Salvo F, Fiorentino A, Dispinzieri M, Caputo M, Di Cosimo S, Mariani G, Gennaro M, Cosentino V, Sant M, Pignoli E, Valdagni R, Lozza L.

Clin Breast Cancer. 2018 Oct;18(5):e1059-e1066. doi: 10.1016/j.clbc.2018.04.003. Epub 2018 Apr 22.

PMID:
29773414
4.

Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer.

Galli G, Bregni G, Cavalieri S, Porcu L, Baili P, Hade A, Di Salvo F, Sant M, Agresti R, Gennaro M, Folli S, De Santis MC, Paolini B, Carcangiu ML, de Braud F, Di Cosimo S.

Breast Care (Basel). 2017 Dec;12(6):391-394. doi: 10.1159/000479582. Epub 2017 Dec 12.

5.

[Excess deaths for haematological tumours in Falconara Marittima (Marche Region, Central Italy): short story from the epidemiological survey up to now].

Di Salvo F, Baili P, Mariottini M, Baldini M, Micheli A, Meneghini E.

Epidemiol Prev. 2017 Sep-Dec;41(5-6):243-247. doi: 10.19191/EP17.5-6.P243.083. Italian.

PMID:
29119757
6.

Socioeconomic deprivation worsens the outcomes of Italian women with hormone receptor-positive breast cancer and decreases the possibility of receiving standard care.

Di Salvo F, Caranci N, Spadea T, Zengarini N, Minicozzi P, Amash H, Fusco M, Stracci F, Falcini F, Cirilli C, Candela G, Cusimano R, Tumino R, Sant M; Socioeconomic Inequalities and Oncological Outcomes Italian Working Group.

Oncotarget. 2017 Jul 22;8(40):68402-68414. doi: 10.18632/oncotarget.19447. eCollection 2017 Sep 15.

7.

Trastuzumab and Hypofractionated Whole Breast Radiotherapy: A Victorious Combination?

De Santis MC, Bonfantini F, Di Salvo F, Fiorentino A, Riboldi VM, Di Cosimo S, Bianchi GV, Gennaro M, Cosentino V, Sant M, Pignoli E, Valdagni R, Lozza L.

Clin Breast Cancer. 2018 Jun;18(3):e363-e371. doi: 10.1016/j.clbc.2017.08.011. Epub 2017 Aug 24.

PMID:
28958838
8.

Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study.

Baili P, Di Salvo F, de Lorenzo F, Maietta F, Pinto C, Rizzotto V, Vicentini M, Rossi PG, Tumino R, Rollo PC, Tagliabue G, Contiero P, Candela P, Scuderi T, Iannelli E, Cascinu S, Aurora F, Agresti R, Turco A, Sant M, Meneghini E, Micheli A.

Support Care Cancer. 2016 May;24(5):2225-2233. doi: 10.1007/s00520-015-3019-8. Epub 2015 Nov 16.

PMID:
26573280
9.

Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study.

Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, Micheli A, Lillini R, Francisci S; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2120-2129. doi: 10.1016/j.ejca.2015.07.025. Epub 2015 Sep 26.

PMID:
26421816
10.

Spatial variation in mortality risk for hematological malignancies near a petrochemical refinery: A population-based case-control study.

Di Salvo F, Meneghini E, Vieira V, Baili P, Mariottini M, Baldini M, Micheli A, Sant M.

Environ Res. 2015 Jul;140:641-8. doi: 10.1016/j.envres.2015.05.022. Epub 2015 Jun 11.

11.

Risk of death for hematological malignancies for residents close to an Italian petrochemical refinery: a population-based case-control study.

Micheli A, Meneghini E, Mariottini M, Baldini M, Baili P, Di Salvo F, Sant M.

Cancer Causes Control. 2014 Dec;25(12):1635-44. doi: 10.1007/s10552-014-0468-1. Epub 2014 Oct 5.

12.

Cancer rehabilitation services: an Italian population-based cohort study.

Di Salvo F, Baili P, Vicentini M, Tumino R, Vercelli M, Pirino D, Contiero P, Foschi R, Minicozzi P, Giorgi Rossi P, De Lorenzo F, Micheli A; CAREMORE Group.

Tumori. 2014 May-Jun;100(3):346-51. doi: 10.1700/1578.17224.

PMID:
25076249
13.

Cancer rehabilitation indicators for Europe.

Baili P, Hoekstra-Weebers J, Van Hoof E, Bartsch HH, Travado L, Garami M, Di Salvo F, Micheli A, Veerus P; EUROCHIP-3 Working group on Cancer Rehabilitation.

Eur J Cancer. 2013 Apr;49(6):1356-64. doi: 10.1016/j.ejca.2012.10.028. Epub 2012 Dec 10.

PMID:
23237740
14.

A method for differentiating cancer prevalence according to health status, exemplified using a population-based sample of Italian colorectal cancer cases.

Baili P, Vicentini M, Tumino R, Vercelli M, Lorenzo M, Foschi R, Guzzinati S, Dal Maso L, Minicozzi P, de Lorenzo F, Micheli A, di Salvo F; CAREMORE Group.

Acta Oncol. 2013 Feb;52(2):294-302. doi: 10.3109/0284186X.2012.743679. Epub 2012 Dec 10.

PMID:
23215872
15.

Cancer research performance in the European Union: a study of published output from 2000 to 2008.

Micheli A, Di Salvo F, Lombardo C, Ugolini D, Baili P, A Pierotti M.

Tumori. 2011 Nov-Dec;97(6):683-9. doi: 10.1700/1018.11081.

PMID:
22322831
16.

Italian performance in cancer research.

Micheli A, Di Salvo F, Lombardo C, Ciampichini R, Ugolini D, Baili P, Pierotti MA.

Tumori. 2009 Mar-Apr;95(2):133-41.

PMID:
19579856

Supplemental Content

Loading ...
Support Center